arbiter
JournalsPricingAccount

Joint model with latent disease age: Overcoming the need for reference time

Juliette Ortholand et al.

Statistical Methods In Medical Research2026https://doi.org/10.1177/09622802251399917article
ABDC B
Weight
0.50

What the paper says

Heterogeneity of the progression of neurodegenerative diseases is one of the main challenges faced in developing therapies. Thanks to the increasing number of clinical databases, progression models have allowed a better understanding of this heterogeneity. Joint models have proven their effectiveness by combining longitudinal and survival data. Nevertheless, they require a reference time, which is ill-defined for neurodegenerative diseases, where biological underlying processes start before the first symptoms. In this work, we propose a joint non-linear mixed-effect model with a latent disease age, to overcome this need for a precise reference time. We used a longitudinal model with a latent disease age as a longitudinal sub-model. We associated it with a survival sub-model that estimates a Weibull distribution from the latent disease age. We validated our model on simulated data and benchmarked it with a state-of-the-art joint model on data from patients with Amyotrophic Lateral Sclerosis (ALS). Finally, we showed how the model could be used to describe ALS heterogeneity. Our model got significantly better results than the state-of-the-art joint model for absolute bias on ALS functional rating scale revised score (4.21(SD 4.41) versus 4.24(SD 4.14)(<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>p</mml:mi></mml:math>-value<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mo>=</mml:mo></mml:math>1.4<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>17</mml:mn></mml:mrow></mml:msup></mml:math>)), and mean-cumulative-AUC for right-censored events on death (0.67(0.07) versus 0.61(0.09)(<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>p</mml:mi></mml:math>-value<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mo>=</mml:mo></mml:math>1.7<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mo>×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>03</mml:mn></mml:mrow></mml:msup></mml:math>)). To conclude, we propose a new model better suited in the context of unreliable reference time.

Open paper page →

Cite this paper

https://doi.org/https://doi.org/10.1177/09622802251399917

Or copy a formatted citation

@article{juliette2026,
  title        = {{Joint model with latent disease age: Overcoming the need for reference time}},
  author       = {Juliette Ortholand et al.},
  journal      = {Statistical Methods In Medical Research},
  year         = {2026},
  doi          = {https://doi.org/https://doi.org/10.1177/09622802251399917},
}

Paste directly into BibTeX, Zotero, or your reference manager.

Flag this paper

Joint model with latent disease age: Overcoming the need for reference time

Flags are reviewed by the Arbiter methodology team within 5 business days.

Evidence weight

0.50

Balanced mode · F 0.40 / M 0.15 / V 0.05 / R 0.40

F · citation impact0.50 × 0.4 = 0.20
M · momentum0.50 × 0.15 = 0.07
V · venue signal0.50 × 0.05 = 0.03
R · text relevance †0.50 × 0.4 = 0.20

† Text relevance is estimated at 0.50 on the detail page — for your query’s actual relevance score, open this paper from a search result.